iRhythm Technologies (IRTC)
(Real Time Quote from BATS)
$100.51 USD
+1.10 (1.11%)
Updated May 15, 2024 11:53 AM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Income Statements
Fiscal Year end for iRhythm Technologies falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 493 | 411 | 323 | 265 | 215 |
Cost Of Goods | 161 | 129 | 109 | 70 | 52 |
Gross Profit | 332 | 282 | 214 | 195 | 162 |
Selling & Adminstrative & Depr. & Amort Expenses | 457 | 395 | 314 | 239 | 217 |
Income After Depreciation & Amortization | -125 | -114 | -100 | -44 | -55 |
Non-Operating Income | 6 | 2 | 0 | 2 | 2 |
Interest Expense | 4 | 4 | 1 | 2 | 2 |
Pretax Income | -123 | -116 | -101 | -44 | -55 |
Income Taxes | 1 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -123 | -116 | -101 | -44 | -55 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -123 | -116 | -101 | -44 | -55 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -114 | -101 | -90 | -37 | -51 |
Depreciation & Amortization (Cash Flow) | 11 | 13 | 10 | 7 | 3 |
Income After Depreciation & Amortization | -125 | -114 | -100 | -44 | -55 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 30.53 | 29.92 | 29.33 | 27.75 | 25.27 |
Diluted EPS Before Non-Recurring Items | -4.04 | -3.88 | -3.46 | -1.58 | -2.16 |
Diluted Net EPS (GAAP) | -4.04 | -3.88 | -3.46 | -1.58 | -2.16 |
Fiscal Year end for iRhythm Technologies falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | 131.93 | 132.51 | 124.60 | 124.13 | 111.44 |
Cost Of Goods | 44.41 | 45.09 | 42.13 | 37.91 | 35.76 |
Gross Profit | 87.52 | 87.43 | 82.47 | 86.23 | 75.68 |
SG&A, R&D, and Dept/Amort Expenses | 125.65 | 115.53 | 110.08 | 105.10 | 115.18 |
Income After SG&A, R&D, and Dept/Amort Expenses | -38.13 | -28.10 | -27.61 | -18.87 | -39.50 |
Non-Operating Income | -4.64 | 1.68 | 1.61 | 1.44 | 1.43 |
Interest Expense | 2.86 | 0.94 | 0.93 | 0.83 | 0.95 |
Pretax Income | -45.64 | -38.44 | -26.92 | -18.27 | -39.02 |
Income Taxes | 0.03 | 0.26 | 0.20 | 0.21 | 0.09 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -45.67 | -38.70 | -27.12 | -18.48 | -39.11 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -45.67 | -38.70 | -27.12 | -18.48 | -39.11 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | 31.03 | 30.70 | 30.61 | 30.50 | 30.30 |
Diluted EPS Before Non-Recurring Items | -1.47 | -1.26 | -0.89 | -0.61 | -1.29 |
Diluted Net EPS (GAAP) | -1.47 | -1.25 | -0.89 | -0.61 | -1.29 |